Search

everythinglearnresearchcommunity

for

Search:↓

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

Metformin helps with PCOS symptoms no matter the patient's initial insulin resistance or weight.

PRP shows potential for treating female hair loss, but more research needed.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Hair proteins have weak spots in their α-helical segments.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Adults with certain skin conditions may have higher levels of inflammation in their body.

Overweight women with PCOS are more likely to have excess male hormones.